| Literature DB >> 18384915 |
Fang Hong1, Luo Ming, Sheng Yi, Li Zhanxia, Wu Yongquan, Liu Chi.
Abstract
Many types of bioactive peptides that inhibit angiotensin I, angiotensin I converting enzyme (ACE) and Ang II type 1 receptor (AT1) in the cardiovascular system contribute to the prevention and treatment of hypertension. These inhibitory peptides are derived from many food proteins or artificial synthetic products. Further research examining the bioavailability of ACE inhibitory peptides will lead to the development of more effective ACE inhibitory peptides and foods. Our research also demonstrates that ACE inhibitory peptide LAP may lower blood pressure with no adverse effects.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18384915 DOI： 10.1016/j.peptides.2008.02.005
Source DB: PubMed Journal: Peptides ISSN： 0196-9781 Impact factor: 3.750